Navigation Links
InterMune Announces Launch of Esbriet® (pirfenidone) in Germany
Date:9/12/2011

t IPF patients in the United States.  At this time pirfenidone is not approved for use in the United States.

About IPF

Idiopathic pulmonary fibrosis (IPF) is a progressive, debilitating and ultimately fatal disease characterized by inflammation and scarring (fibrosis) in the lungs, hindering the ability to process oxygen.  IPF is a progressive disease, meaning that over time, lung scarring and symptoms increase in severity.  The median survival time from diagnosis is two to five years, with a five-year survival rate of approximately 20-40 percent, which makes IPF more rapidly lethal than many cancers, including breast, ovarian and colorectal.  An estimated 30,000-35,000 new cases of IPF are diagnosed in Europe each year. Patients diagnosed with IPF are primarily between the ages of 40 and 80, with a median age of 63 years.  The disease tends to affect slightly more men than women.  

About InterMune

InterMune is a biotechnology company focused on the research, development and commercialization of innovative therapies in pulmonology and fibrotic diseases.  In pulmonology, InterMune is focused on therapies for the treatment of idiopathic pulmonary fibrosis (IPF), a progressive and fatal lung disease.  Pirfenidone, the only medicine approved worldwide for IPF, is approved for marketing by InterMune in the EU as Esbriet® and is currently in a Phase 3 clinical trial in the United States.  Pirfenidone is also approved for the treatment of IPF in Japan, where it is marketed by Shionogi & Co. Ltd. under the trade name Pirespa®.  InterMune's research programs are focused on the discovery of targeted, small-molecule therapeutics and biomarkers to treat and monitor serious pulmonary and fibrotic diseases.  For additional information about InterMune, please visit www.intermune.com.

Forward-Looking Statements


'/>"/>
SOURCE InterMune, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. InterMune to Provide Overview of Corporate Strategy, Update on Esbriet Commercialization Plans in the EU and Details of Phase 3 ASCEND Study
2. InterMune Receives European Union Approval for Esbriet® (pirfenidone)
3. InterMune Reports Fourth Quarter and Full Year 2010 Financial Results and Business Highlights
4. InterMune to Present at J.P. Morgan Healthcare Conference
5. InterMune Reports Third Quarter 2010 Financial Results
6. InterMune Announces Four Oral Presentations on Pirfenidone and IPF at the Annual Congress of the European Respiratory Society (ERS)
7. InterMune to Release Second Quarter Financial Results on July 27
8. InterMune Announces Conference Call and Webcast to Discuss Outcome of FDA Advisory Committee
9. FDA Advisory Committee Recommends Approval of InterMunes Esbriet(R) (pirfenidone) for Idiopathic Pulmonary Fibrosis
10. InterMune Announces Posting of Briefing Documents for FDA Advisory Committee Meeting on Pirfenidone
11. InterMune Reports Fourth Quarter and Full Year 2009 Financial Results and Business Highlights
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/23/2015)... MYERS, Fla. , Jan. 23, 2015  Today the ... of Novartis, Bexsero® for the prevention of serogroup ... 25. Bexsero and Pfizer,s vaccine Trumenba®, which received FDA ... helping prevent this devastating disease. "I ...
(Date:1/23/2015)... 23, 2015 A lot of discussion in the medical ... certain illnesses, injuries, or conditions. As medical science advances, doctors ... with ones that they consider to be more cutting edge. ... one textbook method of treatment that stands out as the ...
(Date:1/23/2015)... Jan. 23, 2015  The Partnership to Fight Chronic Disease (PFCD) released ... care leaders and a new study analyzing the impact of increased ... a nationwide coalition working to educate policy makers and the public ... Capitol was focused on how the Iowa ...
Breaking Medicine Technology:The National Meningitis Association (NMA) Applauds FDA Approval of Second Vaccine To Protect Against Serogroup B Meningococcal Disease 2No One-Size-Fits-All Remedy for Hernia Correction 2New research shows Iowa health exchange would benefit from improvements 2New research shows Iowa health exchange would benefit from improvements 3
... SAN FRANCISCO, Calif., May 10, 2011 Janssen ... Alzheimer,s Immunotherapy Program, Pfizer Inc., is pleased to ... health organization in Alzheimer,s care, support and research, ... Summits Climb for Alzheimer,s: Memories are Everything ...
... Vista Partners announced today that it ... (AMEX: HBP, TSX: HBP) ("the Company") with a twelve ... at Vista Partners stated, "The Company is developing products ... and most advanced, Interferon alpha-2b, is a potent immuno-modulatory ...
Cached Medicine Technology:Alzheimer's Association Salutes Advocate and Mountaineer Now Climbing Everest as Part of The 7 Summits Climb for Alzheimer's 2Alzheimer's Association Salutes Advocate and Mountaineer Now Climbing Everest as Part of The 7 Summits Climb for Alzheimer's 3Alzheimer's Association Salutes Advocate and Mountaineer Now Climbing Everest as Part of The 7 Summits Climb for Alzheimer's 4Vista Partners Initiates Coverage on Helix BioPharma Corporation; Target Price $6.20 2
(Date:1/22/2015)... City, Florida (PRWEB) January 22, 2015 IsoComforter, ... cold therapy machine with patented IsoTube design to treat specific ... has introduced the most progressive and easy to use patented ... treat post-operative and sports related orthopedic and muscle injuries. ...
(Date:1/22/2015)... Payday lending practices in four southern states ... distress to the states that permit them, according to ... on Race and Wealth. , While they generate hundreds ... at the same time substantially depress economic activity, according ...
(Date:1/22/2015)... 2015 As interest in the value of ... momentum worldwide, Rev. Eric J. Hall , president and ... (HCCN), will be the keynote speaker on January 27 at ... health system. , The conference, “Hope and Resilience: Innovative and ...
(Date:1/22/2015)... Compare-autoinsurance.org has released a new blog post presenting a ... insurance policy . , Some types of vehicles cannot be ... newly released blog post to see if their vehicle qualifies for ... are some of the cars that cannot be covered by a ...
(Date:1/22/2015)... 22, 2015 Step into a macabre ... Science Museum of Virginia. Wicked Plants, the Museum’s latest ... unearths 75 poisonous, carnivorous and diabolical plants inside of ... to uncover the biochemical, physical and neurological processes between ...
Breaking Medicine News(10 mins):Health News:IsoComforter Introduces Best of Class Cold Therapy Product to the Worldwide Market 2Health News:Howard University Spotlights the Economic Impact of Payday Lending in Southern States 2Health News:HealthCare Chaplaincy CEO to Keynote Spiritual Care Summit in Israel 2Health News:HealthCare Chaplaincy CEO to Keynote Spiritual Care Summit in Israel 3Health News:Some Vehicles Cannot Be Covered By An Auto Insurance Policy! 2Health News:Wicked Plants are taking over the Science Museum of Virginia 2
... “Hi, who’s on ... tone in her voice. A caller named Mary Ellen describes “very swollen legs from ... Maggie McDermott, RN, deadpans in her Irish brogue. “Now Magster, let’s not start right ... ...
... Key ... , ... 19, 2009 -- Key Metric Software has released Duplicate File Detective v3.0, a major ... a number of new features that focus on extending the scalability and ...
... minutes before intercourse significantly postponed orgasm, study finds , THURSDAY, ... first potential treatment for premature ejaculation has proved effective in ... , PSD502 -- which combines the drugs lidocaine and prilocaine ... intercourse. , The study of men in Canada, Poland and ...
... ... its 9th Annual Conference on Contemporary Pharmacovigilance and Risk Management Strategies from January 10-13, ... ... will host its 9th Annual Conference on Contemporary Pharmacovigilance and Risk Management ...
... MELVILLE, N.Y., Nov. 19 Long Island IVF, a full ... patients achieve successful pregnancies, is now offering a new program ... treatment. Through this program and a partnership with In Vitro ... amount of money couples pay for their comprehensive treatment plans ...
... Washington State Nurses Association (WSNA), representing more than 1,600 ... press conference today to highlight serious concerns about the safety ... this H1N1 pandemic. In response to numerous reports from ... hospital fully comply with CDC guidelines on H1N1 prevention and ...
Cached Medicine News:Health News:New National Nurse Talk Radio Show Takes Off with Humor, Health, and a Voice for the Patient Advocate 2Health News:New National Nurse Talk Radio Show Takes Off with Humor, Health, and a Voice for the Patient Advocate 3Health News:Duplicate File Detective v3.0 Provides Enterprise-Grade Duplicate File Management 2Health News:Spray May Delay Ejaculation 2Health News:DIA Safety Conference To Explore Solutions To Challenges Facing Pharmaocovigilance And Risk Management Strategies 2Health News:DIA Safety Conference To Explore Solutions To Challenges Facing Pharmaocovigilance And Risk Management Strategies 3Health News:Long Island IVF to Offer IVF Financial Share Program, Limiting Costs and Providing Refunds if IVF is Not Successful 2Health News:Respirators and H1N1 Information Distributed to Registered Nurses at Sacred Heart Medical Center Out of Concern for Nurse and Patient Safety 2Health News:Respirators and H1N1 Information Distributed to Registered Nurses at Sacred Heart Medical Center Out of Concern for Nurse and Patient Safety 3
... management software - was designed by ... improvement tool helps diabetes care providers ... bridges medicine with technology by providing ... information technology product. This diabetes ...
... making decisions about insulin dosages and other ... are guided by data from blood glucose ... the patterns that can be seen by ... the data is presented in organized and ...
... The Ex-PRESS ... that provides a simplified,method of ... open angle glaucoma.,Similar to trabeculectomy, ... pressure,by diverting the aqueous humor ...
... StabilEyes CTR is a device designed for ... during cataract removal surgery. It provides secondary ... compromised zonules. The CTR is a uniplanar, ... ultraviolet light absorbing polymethylmethacrylate (PMMA) with one ...
Medicine Products: